Maiwald at LSPN North America Spring 2026 in Boston | April 29th-30th

Maiwald will once again participate in the most influential IP conference for the life sciences this year – and is proud to serve as a Gold Sponsor.

The annual LSPN Spring conference in Boston is a key meeting point for cutting‑edge insights into IP challenges across the pharmaceutical, biotechnology, and medical device industries.

We are delighted that Dr. Anja Fux and Dr. Eva Ehlich will jointly deliver a presentation at this year’s conference on “Assessing inventive step in Europe – Diverging standards at the EPO and the UPC?” In addition, Dr. Gisela Gerstberger will be on site to take part in the discussions and networking.

At a time when the life sciences IP landscape is evolving rapidly, this leading conference brings together top innovators and thought leaders to discuss strategic IP protection—from advanced therapies to market dominance. The program features 20+ high‑impact sessions on patent developments across the Americas, Europe, and Asia, as well as targeted networking with more than 350 senior decision‑makers.

We look forward to insightful discussions on litigation, prosecution, and commercialization strategies, and to exchanging views on the trends shaping the life sciences IP landscape.